EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Delayed and deferred surgery associated with cenobamate use in people with drug‐resistant focal epilepsy

Jacob Pellinen iD, Stefan Sillau iD, Aimee Bui iD, Alexandra Danciutiu, Lesley Kaye iD, Ashvin Sood, Louis Ferrari iD, William E Rosenfeld iD, Christopher Elder iD

Epilepsia · 2026

DOI: 10.1002/epi.70215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2026. Verfasst von Jacob Pellinen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Anticonvulsants, Epilepsies, Partial, Carbamates. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: SK Life Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Cenobamate has been shown to be an effective antiseizure medication for some patients with drug‐resistant focal epilepsy being considered for epilepsy surgery. This retrospective single‐center study evaluated whether surgery was obtained within 12 months for patients who received cenobamate as a treatment during the presurgical evaluation and those who did not, comparing across years before and after cenobamate approval.

Methods

Patients undergoing surgical evaluation for drug‐resistant focal epilepsy at the University of Colorado during 2018 and 2023 who had 12 months of follow‐up data were analyzed. Comparison years were also chosen to avoid the confounding effect of the COVID‐19 pandemic on surgical volume (2020–2021). This allowed for comparison times before and after cenobamate's US Food and Drug Administration approval. The primary outcome (surgery within 12 months) was modeled with potential explanatory variables using multiple logistic regression. A p ‐value of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistant EpilepsyAnticonvulsantsEpilepsies, PartialCarbamatesChlorophenolsTetrazolesHumansFemaleMaleRetrospective StudiesAdultTreatment DelayMiddle AgedYoung AdultAdolescent

Stichwörter der Autor:innen

antiepileptic drug (AED)antiseizure medication (ASM)drug‐resistant epilepsy (DRE)refractory epilepsy/pharmacoresistant epilepsytime to surgery

Substanzen

AnticonvulsantsCenobamateCarbamatesChlorophenolsTetrazoles

Autor:innen und Institutionen

  • Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • College of Osteopathic Medicine, Rocky Vista University, Englewood, Colorado, USA.
  • SSM Health, Fond du Lac, Wisconsin, USA.
  • SK Life Science, Paramus, New Jersey, USA.
  • Comprehensive Epilepsy Care Center for Children and Adults, St. Louis, Missouri, USA.
  • New York University Grossman School of Medicine and New York University Langone Health, New York, New York, USA.

ORCID-Profile: Jacob Pellinen, Stefan Sillau, Aimee Bui, Lesley Kaye, Louis Ferrari, William E Rosenfeld, Christopher Elder

Förderung

  • SK Life Science

Zitieren

APA

Pellinen, J., Sillau, S., Bui, A., Danciutiu, A., Kaye, L., Sood, A., Ferrari, L., Rosenfeld, W. E., & Elder, C. (2026). Delayed and deferred surgery associated with cenobamate use in people with drug‐resistant focal epilepsy. Epilepsia. https://doi.org/10.1002/epi.70215

Vancouver

Pellinen J, Sillau S, Bui A, Danciutiu A, Kaye L, Sood A, et al. Delayed and deferred surgery associated with cenobamate use in people with drug‐resistant focal epilepsy. Epilepsia. 2026. doi:10.1002/epi.70215

BibTeX
@article{Pellinen2026,
  author = {Pellinen, Jacob and Sillau, Stefan and Bui, Aimee and Danciutiu, Alexandra and Kaye, Lesley and Sood, Ashvin and Ferrari, Louis and Rosenfeld, William E and Elder, Christopher},
  title = {Delayed and deferred surgery associated with cenobamate use in people with drug‐resistant focal epilepsy},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1002/epi.70215}
}
Kostenlos starten →